C-Reactive Protein and Neutrophil/Lymphocytes Ratio: Prognostic Indicator for Doubling Overall Survival Prediction in Pancreatic Cancer Patients

Background: Despite modern chemotherapy regimens, survival of patients with locally advanced/metastatic pancreatic cancer remains dismal. Long-term survivors are rare and there are no prognostic scores to identify patients benefitting most from chemotherapy. Methods: This retrospective study include...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlick, Konstantin, Magnes, Teresa, Huemer, Florian, Ratzinger, Lukas, Weiss, Lukas, Pichler, Martin, Melchardt, Thomas, Greil, Richard, Egle, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912559/
https://www.ncbi.nlm.nih.gov/pubmed/31717722
http://dx.doi.org/10.3390/jcm8111791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912559/
https://www.ncbi.nlm.nih.gov/pubmed/31717722
http://dx.doi.org/10.3390/jcm8111791

Ejemplares similares